baber/WOPTO huggingface dataset:
Patent CA-3077119-A1 (CA)
Inventor: INGRAM-TEDD ANDREW JOHN
IPC: B65G1/04
Filed: 2018-10-03
Abstract: La présente invention concerne un dispositif de transport qui est destiné à former un groupe ayant une topologie physique reconfigurable. Selon la présente invention, un dispositif de transport est destiné à coopérer avec une partie d'une surface. Le dispositif de transport est destiné à coopérer avec au moins un autre dispositif de transport dans un groupe ayant une topologie physique reconfigurable. Le dispositif de transport comprend un espace de réception d'article et une unité de repositionnement destinée à permettre le repositionnement du dispositif de transport dans le groupe au moyen d'une interaction avec la partie de la surface. La présente invention concerne également un dispositif de transport destiné à coopérer avec au moins un autre dispositif de transport dans un groupe ayant une topologie physique reconfigurable. Le dispositif de transport comprend un espace de réception d'article et une unité de repositionnement destinée à permettre le repositionnement du dispositif de transport dans le groupe au moyen d'une interaction avec l'au moins un autre dispositif de transport.
Patent CA-3081562-A1 (CA)
Inventor: HUGHES JOHN E
IPC: E04C2/284
Filed: 2018-10-22
Abstract: The present invention is directed to a flame-retardant building panel comprising a body having a first major surface opposite a second major surface, an inorganic coating atop the first major surface, the inorganic coating comprising a flame retardant component that includes a phosphate compound, and a metal complexing agent, wherein the phosphate compound and the metal complexing agent are present in a weight ratio ranging from about 50: 1 to about 200: 1.
Patent CA-3081639-A1 (CA)
Title: Coordinated frequency usage in multi-ap environments
Inventor: ANSLEY CAROL J
IPC: H04W74/00
Filed: 2018-10-31
Abstract: Systems and methods for operating an access point in a wireless network so as to reduce congestion. The access point may have a transmitter capable of broadcasting a beacon indicating a channel over which the access point propagates wireless data. The channel broadcast by the access point may be optimized for future cooperative use of the channel with a second access point.
Patent CA-3082266-A1 (CA)
Inventor: WATERMAN DAVID
IPC: B01L3/00
Filed: 2018-11-23
Abstract: Un dispositif microfluidique pour analyser un liquide d'essai comprend : un capteur (235), tel qu'une membrane pourvue de nanopores, disposé dans une chambre de détection (237); un canal d'entrée de chambre de détection (261) et un canal de sortie de chambre de détection (262), chacun étant relié à la chambre de détection pour faire passer respectivement le liquide à l'intérieur et à l'extérieur de la chambre de détection, et un réservoir (233) formant un orifice d'entrée d'échantillon sur le dispositif microfluidique, le réservoir étant en communication fluidique avec le canal d'entrée de chambre de détection (261); un canal de collecte de liquide (232); une barrière (231) entre une extrémité du canal de sortie de chambre de détection (262) et le canal de collecte de liquide (232); un premier joint d'étanchéité (251), recouvrant l'orifice d'entrée d'échantillon; un second joint d'étanchéité (252), recouvrant l'extrémité du canal de sortie de chambre de détection (262), empêchant ainsi le liquide de s'écouler depuis la chambre de détection (237), au-dessus la barrière (231), dans le canal de collecte de liquide (232); le dispositif microfluidique étant rempli d'un liquide à partir du premier joint d'étanchéité (251) au niveau de l'orifice d'entrée d'échantillon au second joint d'étanchéité (252), de telle sorte que le capteur (235) est recouvert par un liquide et non exposé à un gaz ou une interface gaz/liquide; et les premier et second joints d'étanchéité (251, 252) sont amovibles pour amener le liquide à s'écouler entre le réservoir et l'extrémité de la sortie de chambre de détection et au-dessus de la barrière.
Patent CA-3082411-A1 (CA)
Title: Apparatus and methods for detecting, quantifying, and providing feedback on user gestures
Inventor: SADARANGANI GAUTAM
IPC: G06F3/01
Filed: 2018-11-13
Abstract: Methods and apparatus related to wearable devices (150) worn at a location on a user's body, which in response to execution of processor-executable instructions (120) detect for the user pose or motion and pose at location proximate to or more distally disposed to the wearable device (150). The apparatus (100) includes a wearable user interface device. The wearable device (150) via an associated processor (104) detects, at least, volume changes in a user's limb. The wearable device (150) generates gesture information from, at least one of, myographic force data, proximity data, and inertial measurement data. The wearable device (150) may be included in a larger apparatus (100). The wearable device (150) or larger apparatus (100) may include methods of operation in which at least one processor (105) generates gesture and/or extremity information and takes at least one tangible action based on the information.
Patent CA-3083346-A1 (CA)
Inventor: IGAWA TOMOYUKI
IPC: C07K16/00
Filed: 2018-11-28
Abstract: The present invention relates to: a ligand-binding molecule, the ligand-binding activity of which is reduced by the cleavage of a cleavage site; a production method for the ligand-binding molecule; a complex formed of the ligand-binding molecule and a ligand; a fusion protein including the ligand-binding molecule and a ligand; and a pharmaceutical composition including the ligand-binding molecule, or a fusion protein of the ligand-binding molecule and a ligand.
Patent CA-3087614-A1 (CA)
Title: Liquid sales management system
Inventor: YAMASHITA NAOYUKI
IPC: B67D1/08
Filed: 2018-11-30
Abstract: This liquid sales management system (101) is provided with a liquid supply system (70) and a sales information management system (250) that are in a shop, and a management server (300) which communicates with the liquid supply system and the sales information management system. The liquid supply system is provided with a pouring device (50) which pours out a liquid (20) into a beverage container (40), an actual flow amount creation unit (110) which calculates the measured flow amount of the liquid poured out of the pouring device into the beverage container, and a transmitting and receiving unit (150). The sales information management system sends sales information to a communication line, and the management server has a consumption amount analysis unit (130) which calculates, as the unsold amount of the liquid, the difference between the apparent liquid amount and the measured flow amount.
Patent CA-3093363-A1 (CA)
Inventor: HARRISON STEPHEN
IPC: C25B1/34
Filed: 2010-04-23
Abstract: ABSTRACT This invention relates to a method for the preparation of lithium carbonate from lithium chloride containing brines. In one embodiment, a lithium chloride containing solution is contacted a sodium hydroxide solution in a reaction vessel to produce a lithium hydroxide solution. The lithium hydroxide is contacted with carbon dioxide gas in a reaction vessel to produce a solution that includes lithium carbonate. The lithium carbonate is separated to produce a product stream and a sodium chloride stream, which can be recycled to the electrochemical cell. Date Recue/Date Received 2020-09-16
Patent CA-3094277-A1 (CA)
Inventor: PREDIERI PAOLO GIULIO
IPC: A61K47/36
Filed: 2019-03-13
Abstract: Disclosed are conjugates between stanozolol and hyaluronic acid or a hyaluronic acid salt, characterised in that stanozolol is conjugated with the carboxyl group of hyaluronic acid or the hyaluronic acid salt via a spacer that forms an ester bond with the hydroxyl group of stanozolol and an ester or amide bond with the carboxyl group of hyaluronic acid or the hyaluronic acid salt. The conjugates according to the invention are useful to prepare hydrogels, injectable hydrogels, hydrogels for external use, creams, lotions, foams, aqueous solutions for intra-articular use, emulsions for ophthalmic use, eyedrops, scaffolds, artificial tissues and culture media.
Patent CA-3094723-A1 (CA)
Title: Portable heated press
Inventor: XU CHAO
IPC: A23L33/105
Filed: 2019-03-25
Abstract: A portable heated press device is disclosed that has an upper and lower member, each having an electrically heated platen, hingedly attached to one another near the platens. The lever design allows for multiplying the force applied to the member. An insulator ring is used to thermally insulate the heat from the platens from the handles of the device. The device can include a locking mechanism at the end opposite the platens to apply and maintain pressing force at the platens. The device can also be opened to 180 degrees to allow one platen to be used as a hot plate.
Patent CA-3096477-A1 (CA)
Title: Procede de preparation d'une 1,2,4-triazolone 2,4,5-trisubstituee
Inventor: HASSFELD JORMA
IPC: A61K31/4196
Filed: 2019-04-03
Abstract: La présente invention concerne des procédés de préparation du composé (I), l'utilisation d'intermédiaires pour préparer ledit composé et sa forme cristalline A
Patent CA-3096807-A1 (CA)
Inventor: BENGTSSON TORBJORN
IPC: A61K38/16
Filed: 2019-02-20
Abstract: In the invention, a pharmaceutical composition is provided, comprising a first and a second peptide. The first peptide is a peptide of the bacteriocin PLNC8 .alpha..beta., wherein the peptide of the bacteriocin PLNC8 .alpha..beta. is a peptide A having at least 90%, 95%, 96%, 97%, 98% or 99% sequence identity (%SI) with SEQ ID NO 1, or a peptide B  having at least 90%, 95%, 96%, 97%, 98% or 99%  sequence identity (%SI) with SEQ ID NO 2. When the first peptide is peptide A, the second peptide B having 14 to 34 amino acids and comprising a peptide having at least 90%>, 95%>, 96%>, 97%>, 98%> or 99%  sequence identity (%SI) with SEQ ID NO 3. When the first peptide is peptide B, the second peptide N having 15 to 29 amino acids and comprising a peptide having at least 90%, 95%, 96%, 97%, 98% or 99% sequence identity (%SI) with SEQ ID NO 4. The pharmaceutical composition further comprises at least one antibiotic. The pharmaceutical composition may be used in the treatment or prophylaxis of a bacterial infection.
Patent CA-3097379-A1 (CA)
Title: Utilisations medicales
Inventor: NAHI HARETH
IPC: A61K31/522
Filed: 2019-04-30
Abstract: La présente invention concerne de manière générale des agents antiviraux destinés à être utilisés dans la prévention de la réactivation du virus de l'herpès chez un patient, le patient ayant reçu une thérapie comprenant des cellules tueuses naturelles (NK) et/ou des lymphocytes T de type NK. L'invention concerne en outre des cellules NK et/ou des lymphocytes T de type NK destinés à être utilisés dans le traitement d'une maladie maligne chez un patient, l'utilisation comprenant l'étape d'administration d'un agent antiviral au patient avec la thérapie cellulaire avec des cellules NK et/ou des lymphocytes T de type NK. L'invention concerne également des compositions pharmaceutiques et des kits.
Patent CA-3101485-A1 (CA)
Title: Disruptor assembly adjustment system and method
Inventor: PHILLIPS JOHN
IPC: D21C11/00
Filed: 2020-12-02
Abstract: ABSTRACT OF THE DISCLOSURE A disruptor adjustment system comprising: a disruptor assembly configured to disrupt a volume of smelt flowing from a smelt spout into a dissolving tank, wherein the disruptor assembly comprises an actuator operatively engaged to a disruptor, a sensor configured to record process data from the recovery boiler; and a control system configured to receive a sensor output signal from the sensor, wherein the sensor output signal indicates the process data at a measured time, wherein the control system is further configured to compare the sensor output signal to a programmed operation range, and to send a disruptor input signal to the disruptor assembly to adjust a disruptor operating condition if the process data of the sensor output signal is outside of the programmed operation range. In certain exemplary embodiments, the sensor is an image capture device. In certain exemplary embodiments, the disruptor assembly can be adjusted remotely.   Date Recue/Date Received 2020-12-02
Patent CA-3101987-A1 (CA)
Title: Microfluidic filter device and method for dissociation of tissue and cell aggregates and enrichment of single cells
Inventor: HAUN JERED
IPC: G01N1/28
Filed: 2019-05-29
Abstract: A microfluidic tissue dissociation and filtration device simultaneously filters large tissue fragments and dissociates smaller aggregates into single cells, thereby improving single cell yield and purity. The device includes an inlet coupled to a first microfluidic channel at an upstream location and a first outlet at a downstream location. A first filter membrane is interposed between the first microfluidic channel and a second microfluidic channel, wherein the second microfluidic channel is in fluidic communication with the first microfluidic channel via the first filter membrane. The first filter membrane operates under a tangential flow format. A second outlet is coupled to a downstream location of the second microfluidic channel and includes a second filter membrane interposed between the second outlet and the second microfluidic channel. The dual membrane device increased single cell numbers by at least 3-fold for different tissue types.
Patent CA-3102463-A1 (CA)
Inventor: LARSEN KRISTIAN
IPC: A61M5/19
Filed: 2019-06-26
Abstract: The invention regards a device for reconstituting a bioactive agent and forming a flowable paste, the device comprising: - a base configured for receiving: - a first container containing a liquid, and - a second container containing the bioactive agent, - a syringe containing a paste forming material, the syringe being attachable to the base, wherein the base has a first conduit for fluidly connecting the first container with the second container and a second conduit for fluidly connecting the second container with the syringe, and wherein the first container is configured to be pressurizable such that when the first and second containers are received at the base, the liquid is forced through the first conduit into the second container, thereby reconstituting the bioactive agent, and the reconstituted bioactive agent is forced through the second conduit into the syringe, such that a paste is formed.
Patent CA-3102520-A1 (CA)
Inventor: BINNER CURT
IPC: A61N5/06
Filed: 2019-06-28
Abstract: A phototherapy system wearable on a portion of a user's face includes a lamp platform and a controller unit disposed on, and electrically coupled to, the lamp platform, and a frame for holding the lamp platform in a fixed orientation on a user's face. The controller unit has an inwardly facing surface directed toward the user's face during use; a rechargeable power source; and a charging receptacle disposed in the inwardly facing surface and in electrical communication with the charging receptacle. In use, the frame holds the lamp platform and controller unit in a relationship such that the spacing between the charging receptacle and a closest surface of the user's face defines a charging receptacle clearance.
Patent CA-3103142-A1 (CA)
Title: Amplification method and primers for use therein
Inventor: MORLEY ALEXANDER ALAN
IPC: C12Q1/6858
Filed: 2019-06-07
Abstract: The present invention relates generally to an improved method of amplifying a nucleic acid region of interest and to primers for use therein. More particularly, the present invention is directed to an improved method of amplifying a nucleic acid region which has resulted from the recombination of two or more immunoglobulin or T cell receptor gene segments and primers for use therein. The method of the present invention is based on the determination that performing the amplification step at an annealing temperature determined relative to the critical annealing temperature unique to a given reaction and/or using optimised primers enables higher levels of sensitivity than have previously been achievable in the context of prior art methods of amplifying rearranged immunological or T cell receptor genes. The method of the present invention is particularly useful where the subject recombination target comprises only one N region. The provision of a highly sensitive yet simple means of detecting specific immunological and T cell receptor nucleic acid recombination events is useful in a range of applications including, but not limited to, the diagnosis and/or monitoring of clonal lymphoid cell populations or disease conditions which are characterised by specific V/D/J recombination events (such as detecting minimal residual disease in leukaemias) or the analysis or identification of immunological or T cell receptor gene regions of interest.
Patent CA-3106390-A1 (CA)
Inventor: EDUARDO SABONGE CUNHA FABIO
IPC: E01F9/658
Filed: 2019-05-24
Abstract: The present securing element (10) pertains to devices and fittings used to mount road (20) and highway signage on posts (30); the collapsible securing element (10) comprises two basic members, namely a first, mounting member (40) based on an "L" profile, i.e. with a branch (40a) provided with at least one pair of cutouts (40b) of oblong format made in the elongate free edge (40c) and an orthogonal branch (40c) provided with at least two oblong orifices (01); a second member (41) for securing or locking the collapsible securing element (10) is obtained from a straight profile (41a) provided with at least a further two oblong orifices (02) that correspond axially to the orifices (01) of the orthogonal branch (40c) such that the latter is held parallel to the profile (41a) of the member (41); said orifices (01) and (02) are traversed by locking screws (PF1) such as to maintain an adjustable space (x) between the two, capable of receiving and of securing the members (40) and (41) to the post (30) by washer (A1) and nut (P1) means; to supplement the collapsible securing element (10), provision is made for at least one pair of screw (PF2) and nut (P2) assemblies, which are secured to the cross member or frame (21) of the signage plate (20) such as to maintain a space (y) corresponding to the thickness of the branch (40a).
Patent CA-3111923-A1 (CA)
Inventor: THERIAULT GERARD
IPC: B25B13/08
Filed: 2021-03-11
Abstract: A coupling nut for sealingly engaging a ferrule of a fluid line to a component of a hydraulic system, has: a shank extending along a central axis and having threads to engage a nipple, the threads extending circumferentially around the central axis, the shank defining an inner passage extending along the central axis and sized to receive the fluid line; and a head extending from the shank circumferentially around the inner passage relative to the central axis, the head:  defining faces circumferentially distributed about the central axis and edges at junctions between the faces, the faces including torque-transmitting faces each facing a direction having a circumferential component relative to the central axis, and having a cross-section in a plane normal to the central axis, the cross-section defining a plurality of symmetry planes containing the central axis, the torque-transmitting faces free of intersection with the plurality of symmetry planes.
Patent CA-3112373-A1 (CA)
Inventor: SOLOVYEV TIMOFEY MIKHAILOVICH
IPC: H04N19/50
Filed: 2019-11-20
Abstract: The present disclosure provides methods and devices of processing a block according to a merge candidate list, the method comprising: constructing a first list according to motion information of neighboring blocks of a current block; obtaining prediction information of the current block; when the prediction information of the current block indicates that a sub-block prediction is applied to the current block, obtaining a uni-prediction candidate for the current block according to the first list; using, the uni-prediction candidate for the current block to perform inter prediction of the current block. According to embodiment of the present disclosure, the regular merge list can be directly used and there is no need to explicitly generate the uni-prediction merge candidate list for sub-block prediction.
Patent CA-3114145-A1 (CA)
Inventor: LUI BENJAMIN
IPC: H04W4/30
Filed: 2021-04-06
Abstract: A system and method for generating recommendations during image capture are provided. The method comprises obtaining a camera live stream from a camera in a user device, the camera live stream including image data of a particular product;  detelmining one or more baseline image features common to images of one or more products of a collection based at least on image analysis of image data of the images of the one or more products of the collection; comparing the one or more baseline image features to one or more image features of the image data of the particular product to generate one or more recommendations; and generating, for display together with the camera live stream on the user device, the one or more recommendations.
Patent CA-3116214-A1 (CA)
Title: Terminal configuration method and apparatus
Inventor: JIANG YINQING
IPC: H04W8/20
Filed: 2018-10-15
Abstract: A termination configuration method and device. The method comprises: when a wireless communication module determines that a SIM card in a terminal is powered up, reading, from the SIM card, SIM card information, including an international mobile subscriber identity (IMSI), a service provider name (SPN) or part of or all information of a global ID (GID); transmitting, to an application processor, the SIM card information acquired by the wireless communication module; and the application processor acquiring an operator parameter according to the SIM card information submitted by the wireless communication module and configuring the terminal. In the invention, a wireless communication module acquire SIM card information from a SIM card when the SIM card is powered up, such that the timing at which an IMSI is to be acquired by a UE unit is advanced.
Patent CA-3116391-A1 (CA)
Title: Recombinant adeno associated virus encoding clarin-1 and uses thereof
Inventor: COREY DAVID P
IPC: A61K48/00
Filed: 2021-04-27
Abstract: Aspects of the disclosure relate to compositions and methods for treating hereditary hearing loss and/or vision loss, for example, due to Usher syndrome, Type 3A.  In some embodiments, the disclosure provides a recombinant adeno-associated virus comprising: (i) an AAV-S capsid protein, and (ii) an isolated nucleic acid comprising a transgene (e.g., a transgene for expressing a clarin-1 protein). The present disclosure also provides methods of treating hereditary hearing loss and/or vision loss (e.g., Usher Syndrome, Type 3A) using the same.
Patent CA-3118193-A1 (CA)
Inventor: DOS SANTOS PAIVA JOANA ISABEL
IPC: G01N15/14
Filed: 2019-10-31
Abstract: Device and method for detecting dispersed extracellular vesicles in a liquid dispersion sample, said method using an electronic data processor for classifying the sample as having, or not having, extracellular vesicles present, the method comprising the use of the electronic data processor for pre-training a machine learning classifier with a plurality of extracellular vesicle liquid dispersion specimens comprising the steps of: emitting a laser modulated by a modulation frequency onto each specimen; capturing a temporal signal from laser light backscattered by each specimen for a plurality of temporal periods of a predetermined duration for each specimen; calculating specimen DCT or Wavelet transform coefficients from the captured signal for each of the temporal periods; using the calculated coefficients to pre-train the machine learning classifier; wherein the method further comprises the steps of: using a laser emitter having a focusing optical system coupled to the emitter to emit a laser modulated by a modulation frequency onto the sample; using a light receiver to capture a signal from laser light backscattered by the sample for a plurality of temporal periods of a predetermined duration; calculating sample DCT or Wavelet transform coefficients from the captured signal for each of the temporal periods; using the pre-trained machine learning classifier to classify the calculated sample coefficients as having, or not having, extracellular vesicles present.